From Pharmaceutical Experience to a Focused Specialty Business
Established with a broad international pharmaceutical perspective, Uniphar Pakistan is now evolving into a focused operating platform with priority in oncology, biosimilars and specialty pharmaceuticals.
Shakeel Javed
Pharmaceutical executive · 25+ years of international experience
Uniphar Pakistan is led by Shakeel Javed, a pharmaceutical executive with more than 25 years of international experience.
Under his leadership, Uniphar combines business development, regulatory, market-access and commercial capabilities with a growing network of international pharmaceutical partners.
Importer, exporter and distribution partner
Uniphar Pakistan operates three complementary business lines.
Oncology Imports
We import high-quality oncology medicines from trusted international manufacturers — including our Argentine partners Varifarma and Kemex — for patients, hospitals and institutions across Pakistan.
- Oncology injectables & oral therapies
- Onco-hematology & supportive care
- Selected biosimilars
Pharmaceutical Exports
We export pharmaceutical products to international markets across the GCC, Central Asia, Africa and Asia, building registrations and distributor partnerships market by market.
- Partner & distributor development
- Registration in destination markets
- Tender & institutional business
Local Distribution
We distribute the products of established local pharmaceutical companies to government institutions, public-sector healthcare organizations and other healthcare institutions.
- Government & institutional supply
- Tender participation
- Supply planning & continuity
A track record built across global markets
International pharmaceutical portfolios managed
International markets supported in expansion
Product registration projects led across global markets
Pharmaceutical, nutraceutical and healthcare brands launched
Partnerships across continents
Built and managed partnerships across Asia, Africa, GCC, CIS and emerging markets.
- Asia
- Africa
- GCC
- CIS
- Emerging markets
From advisory to an integrated pharmaceutical platform
The business is moving from a predominantly advisory model toward an integrated pharmaceutical platform.
Consulting & strategic advisory
Consulting and strategic advisory capabilities remain part of our DNA.
- Business development
- Regulatory advisory
- Market entry strategy
Integrated pharmaceutical platform
Our primary proposition is now built around:
- Oncology imports
- Pharmaceutical exports
- Local distribution
- Partnerships
- Licensing
- Registration
- Commercialization
Our ambition
To build Uniphar Pakistan into a recognized specialty-pharma platform serving oncology and complex therapeutic needs through trusted global partnerships, strong regulatory standards and disciplined commercial execution.
Our commitment
We believe that access to high-quality specialty medicines depends on strong partnerships, rigorous regulatory standards, dependable supply and commercially sustainable models. Uniphar aims to bring these elements together under one focused pharmaceutical platform.
Explore a Partnership
Let’s build the next generation of specialty pharmaceutical opportunities together.